Evidence map›Paper›PMID 28636782›Full record

Observational studyLiver international : official journal of the International Association for the Study of the Liver2018

Changing trends in complications of chronic hepatitis C.

Mei Lu, Jia Li, Loralee B Rupp, Yueren Zhou, Scott D Holmberg, Anne C Moorman, Philip R Spradling, Eyasu H Teshale, Joseph A Boscarino, Yihe G Daida and 3 more

Abstract readObservational Study
In one paragraph

Observational study in Liver international : official journal of the International Association for the Study of the Liver, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Decreasing mortality and disease severity in hepatitis C patients awaiting liver transplantation in the United States.Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society · 2018
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Mei LuDepartment of Public Health Sciences, Henry Ford Health System, Detroit, MI, USA.ORCID 0000-0002-3313-6428
Jia LiDepartment of Public Health Sciences, Henry Ford Health System, Detroit, MI, USA.
Loralee B RuppCenter for Health Policy and Health Services Research, Henry Ford Health System, Detroit, MI, USA.
Yueren ZhouDepartment of Public Health Sciences, Henry Ford Health System, Detroit, MI, USA.
Scott D HolmbergDivision of Viral Hepatitis, National Center for HIV, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Anne C MoormanDivision of Viral Hepatitis, National Center for HIV, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Philip R SpradlingDivision of Viral Hepatitis, National Center for HIV, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Eyasu H TeshaleDivision of Viral Hepatitis, National Center for HIV, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Joseph A BoscarinoDepartment of Epidemiology and Health Services Research, Geisinger Health System, Danville, PA, USA.
Yihe G DaidaCenter for Health Research, Kaiser Permanente-Hawai'i, Honolulu, HI, USA.
Mark A SchmidtCenter for Health Research, Kaiser Permanente-Northwest, Portland, OR, USA.
Sheri TrudeauDepartment of Public Health Sciences, Henry Ford Health System, Detroit, MI, USA.
Stuart C GordonDivision of Gastroenterology and Hepatology, Henry Ford Health System, Detroit, MI, USA.

Funding

Chronic Hepatitis Cohort Study–II (CHeCS–II)U18PS005154 · PS · HENRY FORD HEALTH SYSTEM · PI GORDON, STUART · 2016 to 2019
$1.4M
Intramural CDC HHS CC999999NCHHSTP CDC HHS U18 PS005154
6 · The paper itself

Abstract

BACKGROUND &

aimsChronic hepatitis C virus (HCV)-related complications have increased over the past decade.

methodsWe used join-point regression modelling to investigate trends in these complications from 2006 to 2015, and the impact of demographics on these trends. Using data from the Chronic Hepatitis Cohort Study (CHeCS), we identified points at which the trend significantly changed, and estimated the annual percent change (APC) in rates of cirrhosis, decompensated cirrhosis and all-cause mortality, adjusted by race, sex and age.

resultsAmong 11,167 adults with chronic HCV infection, prevalence of cirrhosis increased from 20.8% to 27.6% from 2006 to 2015, with adjusted annual percentage change (aAPC) of 1.2 (p <. 01). Although incidence of all-cause mortality increased from 1.8% in 2006 to 2.9% in 2015, a join-point was identified at 2010, with aAPCs of 9.6 before (2006 < 2010; p < .01) and -5.2 after (2010 ≤ 2015; p < .01), indicating a decrease in mortality from 2010 and onward. Likewise, overall prevalence of decompensated cirrhosis increased from 9.3% in 2006 to 10.4% in 2015, but this increase was confined to patients 60 or older (aAPC = 1.5; p = .023). Asian American and Black/African American patients demonstrated significantly higher rates of cirrhosis than White patients, while older patients and men demonstrated higher rates of cirrhosis and mortality.

conclusionsAlthough cirrhosis and mortality among HCV-infected patients in the US have increased over the past decade, all-cause mortality has decreased in recent years.

Indexed as

AdultAge DistributionAge FactorsAsianBlack or African AmericanCause of DeathHepatitis C, ChronicHumansIncidenceLiver CirrhosisMiddle AgedPrevalenceRisk FactorsSex DistributionSex FactorsTime FactorsAfrican AmericansAsian Americanscirrhosisdecompensated cirrhosis

Identifiers

PMID28636782
PMCPMC5777910

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.